ClinVar Miner

Submissions for variant NM_000057.4(BLM):c.2098C>T (p.Gln700Ter)

gnomAD frequency: 0.00002  dbSNP: rs367543028
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000317685 SCV000329113 pathogenic not provided 2022-05-18 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 28232778, 26786923, 29625052, 26689913, 17407155)
Labcorp Genetics (formerly Invitae), Labcorp RCV000034893 SCV000543350 pathogenic Bloom syndrome 2024-01-24 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gln700*) in the BLM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLM are known to be pathogenic (PMID: 17407155). This variant is present in population databases (rs367543028, gnomAD 0.002%). This premature translational stop signal has been observed in individuals with Bloom syndrome (PMID: 17407155). ClinVar contains an entry for this variant (Variation ID: 42067). For these reasons, this variant has been classified as Pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000034893 SCV000916688 pathogenic Bloom syndrome 2018-09-14 criteria provided, single submitter clinical testing Variant summary: BLM c.2098C>T (p.Gln700X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.2207_2212delinsTAGATTC (p.Tyr736fsX5) and c.2695C>T (p.Arg899X)). The variant allele was found at a frequency of 1.1e-05 in 277168 control chromosomes (gnomAD). c.2098C>T has been reported in the literature, in homozygosity or compound heterozygosity, in multiple individuals affected with Bloom Syndrome (German_2007). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating the variant impact. The most pronounced variant effect in homozygous individuals resulted in <20% mRNA amount compared to normal, based on Northern blot analyses (German_2007). Three ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Ambry Genetics RCV001014425 SCV001175127 pathogenic Hereditary cancer-predisposing syndrome 2021-10-20 criteria provided, single submitter clinical testing The p.Q700* pathogenic mutation (also known as c.2098C>T), located in coding exon 8 of the BLM gene, results from a C to T substitution at nucleotide position 2098. This changes the amino acid from a glutamine to a stop codon within coding exon 8. This alteration has been reported in both a homozygous and compound heterozygous state in multiple individuals with Bloom syndrome (German J et al. Hum. Mutat., 2007 Aug;28:743-53). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Revvity Omics, Revvity RCV000034893 SCV002018440 pathogenic Bloom syndrome 2022-03-02 criteria provided, single submitter clinical testing
Baylor Genetics RCV000034893 SCV004210893 pathogenic Bloom syndrome 2024-03-18 criteria provided, single submitter clinical testing
Counsyl RCV000034893 SCV000485410 pathogenic Bloom syndrome 2015-12-07 no assertion criteria provided clinical testing
Natera, Inc. RCV000034893 SCV002088031 pathogenic Bloom syndrome 2017-03-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.